Key facts
- This page summarizes Christopher D. Maggiore's Form 4 filing for Zivo Bioscience, Inc. (ZIVO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 Jan 2026, 17:09.
Christopher D. Maggiore - 14 Jan 2026 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- ZIVO
- Reported as of
- 14 Jan 2026
- Net transaction value
- +$14,993
- SEC form
- 4
- Accepted by SEC
- 27 Jan 2026, 17:09:32 UTC
- Prior SEC filing
- 09 Oct 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher D. Maggiore
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Christopher D. Maggiore filed Form 4 for Zivo Bioscience, Inc. (ZIVO) on 27 Jan 2026.
Change
- Previous filing in this sequence was filed on 09 Oct 2025.
- Current net transaction value: +$14,993.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001436075
Primary reporting owner
Maggiore Christopher D.
- Relationship
- Director, 10%+ Owner
- Address
- 2125 BUTTERFIELD ROAD, SUITE 100, TROY
- Signature
- /s/ Christopher D. Maggiore
- Signature date
- 27 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZIVO
transaction
Common Stock
Purchase
- Transaction value
- $14,993
- Shares
- +1,766
- Change %
- +0.34%
- Price
- $8.49
- Shares after
- 519,292
- Date
- 14 Jan 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.